Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (19)

2022

  1. Emesis y quimioterapia. Más allá de los setrones y los antagonistas del receptor NK1

    Revisiones en Cancer, Vol. 36, Núm. 2, pp. 104-112

  2. Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study

    Journal of Clinical Medicine, Vol. 11, Núm. 7

2021

  1. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

  2. Electronic health records and patient registries in medical oncology departments in Spain

    Clinical and Translational Oncology, Vol. 23, Núm. 10, pp. 2099-2108

2020

  1. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1205-1215

2019

  1. Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

    Frontiers in Oncology, Vol. 9

  2. Primary malignant melanoma of the biliary tract: A case report and literature review

    World Journal of Clinical Cases, Vol. 7, Núm. 16, pp. 2302-2308

  3. Tratamiento perioperatorio en cáncer de vejiga: Revisión de la literatura

    Revisiones en Cancer, Vol. 33, Núm. 5, pp. 210-215

2018

  1. Epidemiología y factores pronósticos de los tumores neuroendocrinos

    Revisiones en Cancer, Vol. 32, Núm. 5, pp. 287-293

  2. Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis—Prognostic and Predictive Factors

    Molecular Diagnosis and Therapy, Vol. 22, Núm. 2, pp. 169-177

  3. Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience

    Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415

2014

  1. Breast cancer management in the elderly

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 351-361

2010

  1. Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))

    Clinical and Translational Oncology

  2. Novel therapeutic approaches to the treatment of metastatic breast cancer

    Cancer Treatment Reviews, Vol. 36, Núm. 1, pp. 33-42

  3. Supportive care for patients with early breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 1, pp. 32-42

2009

  1. Metástasis única en próstata de carcinoma microcítico pulmonar

    Archivos Espanoles de Urologia, Vol. 62, Núm. 2, pp. 141-144

2007

  1. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225

  2. The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials

    Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774

2001

  1. Tumor de Wilms del adulto

    Archivos Espanoles de Urologia, Vol. 54, Núm. 4, pp. 370-374